Detalhe da pesquisa
1.
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain.
Ann Hematol
; 102(2): 447-456, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36422672
2.
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19.
Am J Hematol
; 97(12): E470-E473, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36111658
3.
Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
Ecancermedicalscience
; 15: 1206, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33912231
4.
Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
Exp Hematol
; 101-102: 49-57, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34403757
5.
Second versus first wave of COVID-19 in patients with MPN.
Leukemia
; 36(3): 897-900, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35064223
6.
A typical acute lymphoblastic leukemia JAK2 variant, R683G, causes an aggressive form of familial thrombocytosis when germline.
Leukemia
; 35(11): 3295-3298, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33846542
7.
Long-term follow-up of recovered MPN patients with COVID-19.
Blood Cancer J
; 11(6): 115, 2021 06 16.
Artigo
Inglês
| MEDLINE | ID: mdl-34135309